$1.37
-9.3%BioSig Technologies, Inc. recently rebranded as Streamex Corp., effective September 12, 2025, following its merger with Streamex Exchange Corporation. The company shifted focus from healthcare technology to real-world asset tokenization, especially integrating the gold and commodities market into blockchain technology. Streamex provides institutional-grade infrastructure for tokenizing assets powered by a gold-denominated treasury.
Strong liquidity. The company has adequate resources to meet short-term liabilities.
Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.
Strong working capital position provides significant operational flexibility and financial cushion.
Capital-intensive business with significant long-term investments in property, equipment, or intangibles.
Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.
STEX โข NASDAQ
| Streamex Corp. Balance Sheet | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
ASSETS | ||||||
CURRENT ASSETS | ||||||
20.3M | 142K | 190K | 357K | 11.7M | 28.3M | |
9.7M | 13K | 103K | 101K | 0.0 | 0.0 | |
30M | 155K | 293K | 458K | 11.7M | 28.3M | |
0.0 | 109K | 24K | 9K | 0.0 | 0.0 | |
0.0 | 109K | 24K | 9K | 0.0 | 0.0 | |
0.0 | 0.0 | 0.0 | 336K | 1.9M | 768K | |
0.0 | 80K | 211K | 325K | 354K | 301K | |
41.9M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
71.9M | 344K | 528K | 1.1M | 13.9M | 29.3M | |
NON-CURRENT ASSETS | ||||||
25K | 185K | 938K | 1.5M | 1.3M | 595K | |
71M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
44.6M | 270K | 289K | 308K | 327K | 347K | |
115.6M | 270K | 289K | 308K | 327K | 347K | |
0.0 | 43K | 43K | 1.2M | 42K | 107K | |
115.6M | 498K | 1.3M | 3M | 1.6M | 1M | |
187.5M | 842K | 1.8M | 4.1M | 15.5M | 30.4M | |
LIABILITIES | ||||||
CURRENT LIABILITIES | ||||||
0.0 | 110K | 101K | 91K | 82K | 0.0 | |
0.0 | 110K | 101K | 91K | 82K | 0.0 | |
0.0 | 2.1M | 4.1M | 2.9M | 2.2M | 935.5K | |
38M | 0.0 | 0.0 | 0.0 | 0.0 | 313K | |
0.0 | 102K | 349K | 313K | 283K | 0.0 | |
0.0 | 0.0 | 16K | 5K | 32K | 0.0 | |
4.8M | 0.0 | 0.0 | 0.0 | 0.0 | 3.9M | |
42.8M | 2.3M | 4.6M | 3.3M | 2.6M | 5.1M | |
NON-CURRENT LIABILITIES | ||||||
0.0 | 0.0 | 0.0 | 0.0 | 5K | 0.0 | |
11.4M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
11.4M | 0.0 | 103K | 452K | 378K | 1K | |
0.0 | 102K | 452K | 765K | 656K | 1K | |
54.2M | 2.3M | 4.7M | 3.7M | 3M | 5.1M | |
SHAREHOLDERS' EQUITY | ||||||
105K | 105K | 105K | 105K | 105K | 105K | |
50K | 17K | 9K | 5K | 36K | 31K | |
850.4M | 253.8M | 242M | 216.3M | 201.1M | 181.3M | |
-718.1M | -255.3M | -245M | -216M | -188.9M | -157M | |
814K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
133.2M | -1.4M | -2.9M | 418K | 12.3M | 24.5M | |
133.2M | -1.4M | -2.9M | 397K | 12.6M | 25.3M | |
32K | 17K | 26K | -21K | 219K | 802K | |
SUMMARY | ||||||
187.5M | 842K | 1.8M | 4.1M | 15.5M | 30.4M | |
9.7M | 13K | 103K | 101K | 0.0 | 0.0 | |
38M | 102K | 452K | 765K | 656K | 314K | |
17.7M | -40K | 262K | 408K | -11M | -28M | |
35,270,944 | 35,270,944 | 35,270,944 | 35,270,944 | 35,270,944 | 35,270,944 |
STEX - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 28, 2026 | May 27, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 27, 2026 | May 26, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 14, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 04, 2026 | April 28, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 10, 2026 | April 08, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 31, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 27, 2026 | March 26, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 20, 2026 | March 16, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 06, 2026 | March 03, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 13, 2026 | February 09, 2026 | 2026 |
Continue your STEX research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.